Endocrinological derangements in COPD.

Area of Science:

• Endocrinology
• Pulmonary Medicine
• Systemic Manifestations of Disease

Background:

• Chronic obstructive pulmonary disease (COPD) is increasingly recognized as a systemic illness, not limited to the lungs and airways.
• Systemic manifestations of COPD encompass various endocrine disorders affecting the pituitary, thyroid, gonads, adrenals, and pancreas.

Purpose of the Study:

• To explore the endocrine disorders associated with COPD.
• To understand the mechanisms linking COPD to endocrine dysfunction.
• To elucidate how endocrine alterations exacerbate COPD's clinical presentation.

Main Methods:

• Review of current research integrating molecular biology, integrative physiology, and clinical trials.
• Analysis of mechanisms including hypoxemia, hypercapnia, inflammation, and glucocorticoid use.
• Examination of how altered endocrine function impacts protein metabolism, the renin-angiotensin-aldosterone system, and fluid balance.

Main Results:

• COPD is associated with endocrine dysfunctions impacting multiple glands.
• Mechanisms like hypoxemia, inflammation, and steroid use contribute to endocrine alterations.
• Endocrine disorders worsen COPD by affecting muscle mass, respiratory mechanics, cardiac function, and fluid balance.

Conclusions:

• Endocrine manifestations are significant systemic effects of COPD.
• Understanding these endocrine disorders is crucial for pulmonary medicine practitioners.
• Addressing endocrine dysfunction may improve COPD management and patient outcomes.